Asia-Pacific Journal of Clinical Oncology

Cover image for Vol. 7 Issue s2

Special Issue: Bevacizumab in Non Small-cell Lung Cancer in Asia

June 2011

Volume 7, Issue Supplement s2

Pages 1–40

  1. Benacizumab in Non Small-cell Lung Cancer in Asia. Publication of this supplement has been supported through an independent educational grant from F. Hoffmann-La Roche AG.

    1. Top of page
    2. Benacizumab in Non Small-cell Lung Cancer in Asia. Publication of this supplement has been supported through an independent educational grant from F. Hoffmann-La Roche AG.
    1. Editorial

      You have free access to this content
    2. Original articles

      Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial (pages 4–12)

      Tony SK MOK, Te-Chun HSIA, Chun-Ming TSAI, Kenneth TSANG, Gee-Chen CHANG, John Wen-Cheng CHANG, Sirisinha THITIYA, Virote SRIURANPONG, Sumitra THONGPRASERT, Daniel TT CHUA, Nicola MOORE and Christian MANEGOLD

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1743-7563.2011.01397.x

      Corrected by:

      Erratum

      Vol. 7, Issue 3, 321, Version of Record online: 28 AUG 2011

    3. An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia (pages 13–21)

      John Wen-Cheng CHANG, Sumitra THONGPRASERT, Elaine WRIGHT, Kenneth TSANG, Heung Tae KIM, Myung-Ju AHN, Joo-Hang KIM, Jin Hyoung KANG, Sang-We KIM and Stefan WALZER

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1743-7563.2011.01398.x

    4. Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan (pages 22–33)

      Myung-Ju AHN, Chun-Ming TSAI, Te-Chun HSIA, Elaine WRIGHT, John Wen-Cheng CHANG, Heung Tae KIM, Joo-Hang KIM, Jin Hyoung KANG, Sang-We KIM, Eun-Jin BAE, Mijeong KANG, Johanna LISTER and Stefan WALZER

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1743-7563.2011.01399.x

    5. Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes (pages 34–40)

      Gee-Chen CHANG, Myung-Ju AHN, Elaine WRIGHT, Heung Tae KIM, Joo-Hang KIM, Jin Hyoung KANG, Sang-We KIM, Steven SHERMAN and Stefan WALZER

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1743-7563.2011.01400.x

SEARCH

SEARCH BY CITATION